<DOC>
	<DOCNO>NCT02278367</DOCNO>
	<brief_summary>This study design expand database 18F-AV-1451 safety tau binding measure PET image provide standardize condition 18F-AV-1451 use , data collection analysis facilitate companion study include , limited , longitudinal study age , depression , traumatic brain injury .</brief_summary>
	<brief_title>Clinical Evaluation 18F-AV-1451</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<criteria>Subjects meet inclusion exclusion criterion companion protocol addition criterion . Subjects historical volumetric MRI part companion study Have clinically significant cardiac , hepatic , renal , pulmonary , metabolic , endocrine disturbance Have screen ECG QTc &gt; 450 msec male QTc &gt; 470 msec female Have history additional risk factor Torsades de Pointes ( TdP ) take drug know cause QTprolongation . Patients prolong QTc interval set intraventricular conduction block may enrol sponsor approval Have history drug alcohol dependence within last year , prior prolonged history dependence unless approve sponsor Are females childbearing potential surgically sterile , refrain sexual activity use reliable method contraception Have history relevant severe drug allergy hypersensitivity Are patient receive investigational medication FDA IND protocol within 30 day prior plan image session study Are patient current clinically significant unstable medical comorbidities Are patient received radiopharmaceutical imaging therapy within past 24 hour prior image session study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>